Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · IEX Real-Time Price · USD
10.60
-0.22 (-2.03%)
At close: May 14, 2024, 4:00 PM
10.54
-0.06 (-0.57%)
After-hours: May 14, 2024, 7:48 PM EDT
Avalo Therapeutics Stock Forecast
AVTX's stock price has decreased by -98.39% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Avalo Therapeutics stock have an average target of 107.5, with a low estimate of 35 and a high estimate of 180. The average target predicts an increase of 914.15% from the current stock price of 10.60.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AVTX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $35 | Hold → Buy | Upgrades | $35 | +230.19% | Apr 16, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $2,160 → $180 | Buy → Hold | Downgrades | $2,160 → $180 | +1,598.11% | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $4,080 → $2,160 | Buy | Maintains | $4,080 → $2,160 | +20,277.36% | May 10, 2023 |
| Jefferies | Jefferies | Hold → Sell Downgrades $720 | Hold → Sell | Downgrades | $720 | +6,692.45% | Feb 8, 2023 |
Financial Forecast
Revenue This Year
1.22M
from 1.92M
Decreased by -36.38%
Revenue Next Year
1.02M
from 1.22M
Decreased by -16.67%
EPS This Year
-17.14
from -114.00
EPS Next Year
-17.14
from -17.14
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.3M | 1.1M | 1.1M | n/a | n/a |
| Avg | 1.2M | 1.0M | 1.0M | n/a | n/a |
| Low | 1.2M | 980,000 | 980,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -34.5% | -14.2% | 2.9% | - | - |
| Avg | -36.4% | -16.7% | - | - | - |
| Low | -38.9% | -19.9% | -3.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -17.64 | -17.64 | -17.64 |
| Avg | -17.14 | -17.14 | -17.14 |
| Low | -16.46 | -16.46 | -16.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.